Gilead Sciences Stock Forecast: Continue Buying This Top Pharmaceutical Stock (GILD)

I Know First published a bullish article on Gilead Sciences, a biopharmaceutical company with specialties addressing HIV and Hepatitis C, on Seeking Alpha. Having explained how I Know First’s algorithm works and providing an example of its success in the past, it is worthwhile to see if the algorithm agrees with the bullish fundamental analysis of the company. The three-month and one-year forecasts for Gilead Sciences are included. gilead sciences stock forecast